These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25352633)

  • 1. Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data.
    Pfützner A; Raz I; Bitton G; Klonoff D; Nagar R; Hermanns N; Haak T
    J Diabetes Sci Technol; 2015 Jan; 9(1):116-22. PubMed ID: 25352633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
    Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
    Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control.
    Pfützner A; Dissel S; Forkel C; Grenningloh M; Bitton G; Nagar R; Forst T
    Curr Med Res Opin; 2014 Oct; 30(10):2001-8. PubMed ID: 24940825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.
    Raz I; Bitton G; Feldman D; Alon T; Pfutzner A; Tamborlane WV
    J Diabetes Sci Technol; 2015 May; 9(3):639-43. PubMed ID: 25883166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of local heating on postprandial blood glucose excursions using the InsuPad device: results of an outpatient crossover study.
    Hermanns N; Bitton G; Reimer A; Krichbaum M; Kulzer B; Haak T
    J Diabetes Sci Technol; 2014 Nov; 8(6):1126-32. PubMed ID: 25113814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
    Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
    Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary protein on post-prandial glucose in patients with type 1 diabetes.
    Borie-Swinburne C; Sola-Gazagnes A; Gonfroy-Leymarie C; Boillot J; Boitard C; Larger E
    J Hum Nutr Diet; 2013 Dec; 26(6):606-11. PubMed ID: 23521532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes.
    Rodriguez LM; Mason KJ; Haymond MW; Heptulla RA
    Pediatr Res; 2007 Dec; 62(6):746-9. PubMed ID: 17957149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
    Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.
    Rave K; Klein O; Frick AD; Becker RH
    Diabetes Care; 2006 Aug; 29(8):1812-7. PubMed ID: 16873785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 18. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
    Singh-Franco D; Robles G; Gazze D
    Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.